HeartSciences (HSCSW) Change in Accured Expenses (2021 - 2026)
HeartSciences posted quarterly Change in Accured Expenses of $68179.0 for Q1 2026, up 333.05% year-on-year from $15744.0 in Q1 2025, and up 120.4% on a QoQ basis from -$334208.0 in Q4 2025.
HeartSciences (HSCSW) has 6 years of Change in Accured Expenses data on file, last reported at $68179.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 333.05% year-over-year to $68179.0; the trailing twelve-month figure through Jan 2026 stood at $162008.0 (up 200.12% YoY), and the FY2025 full-year result was $16791.0, up 128.61% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $68179.0, up from -$334208.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $371484.0 in Q2 2022 and bottomed at -$477475.0 in Q3 2022.
- The 5-year median for Change in Accured Expenses is $15744.0 (2025), against an average of $12728.1.
- The widest annual swing landed in 2022, when Change in Accured Expenses plunged 997.02%; it then soared 472.92% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at $247141.0 in 2022, then plunged by 126.67% to -$65901.0 in 2023, then tumbled by 227.11% to -$215566.0 in 2024, then sank by 55.04% to -$334208.0 in 2025, then surged by 120.4% to $68179.0 in 2026.
- The last three Change in Accured Expenses figures came in at $68179.0 (Q1 2026), -$334208.0 (Q4 2025), and $166718.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 74.30 Mn |
| 10 | HeartSciences | - | - | - | 68,179.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 68,179.00 |
| Jan 31, 2026 | 68,179.00 |
| Oct 31, 2025 | -334,208.00 |
| Oct 31, 2025 | -334,208.00 |
| Jul 31, 2025 | 166,718.00 |
| Jul 31, 2025 | 166,718.00 |
| Apr 30, 2025 | 261,319.00 |
| Apr 30, 2025 | 261,319.00 |
| Jan 31, 2025 | 15,744.00 |
| Jan 31, 2025 | 15,744.00 |
| Oct 31, 2024 | -215,566.00 |
| Oct 31, 2024 | -215,566.00 |
| Jul 31, 2024 | -44,706.00 |
| Jul 31, 2024 | -44,706.00 |
| Apr 30, 2024 | 82,718.00 |
| Apr 30, 2024 | 82,718.00 |
| Jan 31, 2024 | -103,237.00 |
| Jan 31, 2024 | -103,237.00 |
| Oct 31, 2023 | -65,901.00 |
| Oct 31, 2023 | -65,901.00 |
| Jul 31, 2023 | 27,730.00 |
| Jul 31, 2023 | 27,730.00 |
| Apr 30, 2023 | -37,346.00 |
| Apr 30, 2023 | -37,346.00 |
| Jan 31, 2023 | -42,466.00 |
| Jan 31, 2023 | -42,466.00 |
| Oct 31, 2022 | 247,141.00 |
| Oct 31, 2022 | 247,141.00 |
| Jul 31, 2022 | -477,475.00 |
| Jul 31, 2022 | -477,475.00 |
| Apr 30, 2022 | 371,484.00 |
| Apr 30, 2022 | 371,484.00 |
| Jan 31, 2022 | 296,250.00 |
| Jan 31, 2022 | 296,250.00 |
| Oct 31, 2021 | 144,380.00 |
| Oct 31, 2021 | 144,380.00 |
| Jul 31, 2021 | 53,229.00 |
| Jul 31, 2021 | 53,229.00 |